Quality Assistance participates in a 81-million-euros-budget Innovation Partnership in ATMPs

Quality Assistance participates in a 81-million-euros-budget Innovation Partnership in Advanced Therapy Medicinal Products (ATMPs). This groundbreaking project showcases a strong commitment to innovation in the field of ATMPs and is led by BioWin and the Service public de Wallonie.

It brings together 26 partners for 12 work packages covering all the links in the ATMP value chain and addressing:

• particular areas of scientific research with high development potential,

• various aspects of preclinical and clinical research,

• innovative approaches to production process design and control.

Quality Assistance is thrilled to contribute to two critical work packages:

1. CARACT’EXO: In partnership with Novadip, we're leading the development of innovative analytical tools for exosome analysis

2. GUIDEPRO: We're collaborating on a project coordinated by Eurogentec to develop a methodology to produce guide RNAs for CRISPR therapeutic gene editing

Watch this video of our R&D and Innovation Director, Arnaud Delobel, as he presents Quality Assistance's participation to this groundbreaking project:

More information:

• Press release

• White paper

• ATMPs PIT portfolio presentation

• ATMPs PIT summary sheet